BIOX Bioceres Crop Solutions Corp

Price (delayed)

$11.22

Market cap

$705.12M

P/E Ratio

224.4

Dividend/share

N/A

EPS

$0.05

Enterprise value

$943.84M

bioceres crop solutions corp., together with its subsidiaries, provides crop productivity solutions. the company operates through three segments: seed and integrated products, crop protection, and crop nutrition. the seed and ...

Highlights
The company's revenue rose by 6% YoY
The equity has grown by 4.3% from the previous quarter and by 4.1% YoY
BIOX's debt is up by 8% since the previous quarter but it is down by 3.3% year-on-year
The stock's price to earnings (P/E) is 131% more than its last 4 quarters average of 97.1
The net income has plunged by 86% from the previous quarter and by 80% YoY

Key stats

What are the main financial stats of BIOX
Market
Shares outstanding
62.85M
Market cap
$705.12M
Enterprise value
$943.84M
Valuations
Price to book (P/B)
2.25
Price to sales (P/S)
1.59
EV/EBIT
24.86
EV/EBITDA
16.54
EV/Sales
2.14
Earnings
Revenue
$441.98M
EBIT
$37.96M
EBITDA
$57.06M
Free cash flow
-$11.79M
Per share
EPS
$0.05
Free cash flow per share
-$0.19
Book value per share
$4.99
Revenue per share
$7.03
TBVPS
$8.75
Balance sheet
Total assets
$836.13M
Total liabilities
$487.6M
Debt
$255.08M
Equity
$313.35M
Working capital
$74.21M
Liquidity
Debt to equity
0.81
Current ratio
1.22
Quick ratio
0.83
Net debt/EBITDA
4.18
Margins
EBITDA margin
12.9%
Gross margin
39.8%
Net margin
0.7%
Operating margin
8.2%
Efficiency
Return on assets
0.4%
Return on equity
1%
Return on invested capital
8.6%
Return on capital employed
7.5%
Return on sales
8.6%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

BIOX stock price

How has the Bioceres Crop Solutions stock price performed over time
Intraday
1.36%
1 week
0.18%
1 month
3.7%
1 year
-8.93%
YTD
-18.28%
QTD
0.09%

Financial performance

How have Bioceres Crop Solutions's revenue and profit performed over time
Revenue
$441.98M
Gross profit
$175.81M
Operating income
$36.04M
Net income
$3.07M
Gross margin
39.8%
Net margin
0.7%
The net income has plunged by 86% from the previous quarter and by 80% YoY
BIOX's net margin has dropped by 86% since the previous quarter and by 81% year-on-year
BIOX's operating margin is down by 40% YoY and by 31% QoQ
The operating income has contracted by 37% YoY and by 32% from the previous quarter

Growth

What is Bioceres Crop Solutions's growth rate over time

Valuation

What is Bioceres Crop Solutions stock price valuation
P/E
224.4
P/B
2.25
P/S
1.59
EV/EBIT
24.86
EV/EBITDA
16.54
EV/Sales
2.14
The stock's price to earnings (P/E) is 131% more than its last 4 quarters average of 97.1
Bioceres Crop Solutions's EPS has plunged by 86% from the previous quarter and by 76% YoY
BIOX's P/B is 46% lower than its 5-year quarterly average of 4.2 and 17% lower than its last 4 quarters average of 2.7
The equity has grown by 4.3% from the previous quarter and by 4.1% YoY
BIOX's P/S is 16% below its last 4 quarters average of 1.9 and 12% below its 5-year quarterly average of 1.8
The company's revenue rose by 6% YoY

Efficiency

How efficient is Bioceres Crop Solutions business performance
BIOX's return on equity has dropped by 86% since the previous quarter and by 84% year-on-year
The ROA has shrunk by 85% QoQ and by 80% YoY
BIOX's return on invested capital is down by 36% year-on-year and by 32% since the previous quarter
Bioceres Crop Solutions's ROS has decreased by 36% YoY and by 31% from the previous quarter

Dividends

What is BIOX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for BIOX.

Financial health

How did Bioceres Crop Solutions financials performed over time
BIOX's total assets is 71% higher than its total liabilities
Bioceres Crop Solutions's current ratio has decreased by 12% YoY
BIOX's total liabilities is down by 4.9% YoY
BIOX's debt is 19% smaller than its equity
Bioceres Crop Solutions's debt to equity has decreased by 8% YoY but it has increased by 2.5% from the previous quarter
BIOX's debt is up by 8% since the previous quarter but it is down by 3.3% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.